Related references
Note: Only part of the references are listed.Assessment of Proarrhythmic Potential of Drugs in Optogenetically Paced Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Dakshesh Patel et al.
TOXICOLOGICAL SCIENCES (2019)
Clinical Trial in a Dish: Personalized Stem Cell-Derived Cardiomyocyte Assay Compared With Clinical Trial Results for Two QT-Prolonging Drugs
Ksenia Blinova et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2019)
Thorough QT/QTc in a Dish: An In Vitro Human Model That Accurately Predicts Clinical Concentration-QTc Relationships
Alexander D. Blanchette et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Genome Editing of Induced Pluripotent Stem Cells to Decipher Cardiac Channelopathy Variant
Priyanka Garg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Cross-Site Reliability of Human Induced Pluripotent stem cell-derived Cardiomyocyte Based Safety Assays Using Microelectrode Arrays: Results from a Blinded CiPA Pilot Study
Daniel Millard et al.
TOXICOLOGICAL SCIENCES (2018)
Response of human induced pluripotent stem cell-derived cardiomyocytes to several pharmacological agents when intrinsic syncytial pacing is overcome by acute external stimulation
Haoyu Zeng et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2018)
International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment
Ksenia Blinova et al.
CELL REPORTS (2018)
Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation
Susanne Rehnelt et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells
Arun Sharma et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells
Francesca Stillitano et al.
ELIFE (2017)
Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes
Tadahiro Shinozawa et al.
STEM CELL REPORTS (2017)
Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes
Hendrik Lapp et al.
SCIENTIFIC REPORTS (2017)
IK1-enhanced human-induced pluripotent stem cell-derived cardiomyocytes: an improved cardiomyocyte model to investigate inherited arrhythmia syndromes
Ravi Vaidyanathan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
Proarrhythmia Risk Assessment in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using the Maestro MEA Platform
Yusheng Qu et al.
TOXICOLOGICAL SCIENCES (2015)
Drug Screening Using a Library of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity
Ping Liang et al.
CIRCULATION (2013)
Mechanism-Based Facilitated Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes
Deborah K. Lieu et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2013)
Structural and Functional Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells
Scott D. Lundy et al.
STEM CELLS AND DEVELOPMENT (2013)
Mechanism of Reverse Rate-Dependent Action of Cardioactive Agents
T. Banyasz et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Reverse rate-dependent changes are determined by baseline action potential duration in mammalian and human ventricular preparations
Laszlo Barandi et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Restricting excessive cardiac action potential and QT prolongation -: A vital role for IKs in human ventricular muscle
N Jost et al.
CIRCULATION (2005)
Rate dependence of the effect of antiarrhythmic drugs delaying cardiac repolarization: an overview
P Dorian et al.
EUROPACE (2000)
Share Paper
